Charles Schwab’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-89,562
| Closed | -$239K | – | 3496 |
|
|
2025
Q1 | $239K | Hold |
89,562
| – | – | ﹤0.01% | 3239 |
|
|
2024
Q4 | $315K | Hold |
89,562
| – | – | ﹤0.01% | 3262 |
|
|
2024
Q3 | $425K | Sell |
89,562
-6,324
| -7% | -$30K | ﹤0.01% | 3201 |
|
|
2024
Q2 | $451K | Buy |
+95,886
| New | +$451K | ﹤0.01% | 3242 |
|
|
2022
Q2 | – | Sell |
-10,306
| Closed | -$79K | – | 3537 |
|
|
2022
Q1 | $79K | Buy |
+10,306
| New | +$79K | ﹤0.01% | 3454 |
|
|
2014
Q2 | – | Sell |
-9
| Closed | -$230K | – | 3088 |
|
|
2014
Q1 | $230K | Hold |
9
| – | – | ﹤0.01% | 2905 |
|
|
2013
Q4 | $163K | Hold |
9
| – | – | ﹤0.01% | 2997 |
|
|
2013
Q3 | $179K | Hold |
9
| – | – | ﹤0.01% | 2952 |
|
|
2013
Q2 | $190K | Buy |
+9
| New | +$190K | ﹤0.01% | 2920 |
|